Jefferies Group LLC Pfizer Inc Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	BUY	$46.53 - $55.17 $7.26 Million - $8.61 Million	156,000 Added 619.05%	181,200 $9.5 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $7.26 Million - $8.61 Million	156,000 Added 619.05%	181,200 $9.5 Million
Q1 2022 Sep 21, 2023	SELL	$45.75 - $56.69 $22.8 Million - $28.2 Million	-497,800 Reduced 95.18%	25,200 $1.3 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $22.8 Million - $28.2 Million	-497,800 Reduced 95.18%	25,200 $1.31 Million
Q4 2021 Sep 21, 2023	SELL	$41.32 - $61.25 $13.5 Million - $20 Million	-327,000 Reduced 38.47%	523,000 $30.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $13.5 Million - $20 Million	-327,000 Reduced 38.47%	523,000 $30.9 Million
Q3 2021 Sep 21, 2023	BUY	$39.25 - $50.42 $31.2 Million - $40 Million	793,900 Added 1415.15%	850,000 $36.6 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $31.2 Million - $40 Million	793,900 Added 1415.15%	850,000 $36.6 Million
Q2 2021 Sep 21, 2023	SELL	$35.91 - $40.68 $3.88 Million - $4.39 Million	-108,000 Reduced 65.81%	56,100 $2.2 Million
Q2 2021 Aug 20, 2021	SELL	$35.91 - $40.68 $199 Million - $226 Million	-5,553,900 Reduced 99.0%	56,100 $2.2 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $196 Million - $222 Million	5,445,900 Added 3318.65%	5,610,000 $2.2 Million
Q4 2020 Sep 21, 2023	SELL	$33.47 - $42.56 $572,337 - $727,776	-17,100 Reduced 9.44%	164,100 $6.04 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $12.4 Million - $15.7 Million	-369,900 Reduced 69.27%	164,100 $6.04 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $12.2 Million - $14.3 Million	383,600 Added 255.05%	534,000 $19.6 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $978,900 - $1.19 Million	-32,500 Reduced 17.77%	150,400 $4.92 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $4.87 Million - $6.96 Million	-180,100 Reduced 49.61%	182,900 $5.97 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $10.7 Million - $12.2 Million	-325,700 Reduced 47.29%	363,000 $14.2 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $7.12 Million - $9.23 Million	219,100 Added 46.66%	688,700 $24.7 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $7.13 Million - $8.01 Million	192,900 Added 69.71%	469,600 $20.3 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $1.15 Million - $1.26 Million	-30,700 Reduced 9.99%	276,700 $11.8 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $44.3 Million - $50.5 Million	-1,150,300 Reduced 78.91%	307,400 $13.4 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $46.3 Million - $56.2 Million	1,343,800 Added 1179.81%	1,457,700 $64.2 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $28.9 Million - $30.8 Million	-877,100 Reduced 88.51%	113,900 $4.13 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $22.5 Million - $26.1 Million	703,700 Added 244.94%	991,000 $35.2 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $9.67 Million - $10.3 Million	-290,600 Reduced 50.29%	287,300 $10.4 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $17.9 Million - $19.7 Million	577,900	577,900 $20.6 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.68 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.33 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.44 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account